Skip to content

Prevalence of May-Thurner Syndrome in 1st-degree Relatives of Symptomatic Patients

Prevalence of May-Thurner Syndrome in 1st-degree Relatives of Symptomatic Patients

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05409781
Acronym
MTS
Enrollment
0
Registered
2022-06-08
Start date
2025-09-15
Completion date
2026-01-15
Last updated
2025-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

May-Thurner Syndrome

Brief summary

The aim is to assess the prevalence of May-Thurner syndrome in 1st-degree relatives of previously identified symptomatic patients.

Detailed description

May-Thurner syndrome (MTS) is a condition characterised by compression of the left common iliac vein by the right common iliac artery and the anterior spine of the 5th lumbar vertebrae. Previously thought to be a rare condition, the prevalence of MTS is thought to be underreported. MTS can lead to significant morbidity in the form of chronic venous insufficiency, venous ulceration, lower limb swelling, venous claudication, deep-vein thrombosis, varicose veins, pelvic congestion syndrome, chronic pelvic pain and chronic post-thrombotic syndrome. It is a known risk factor for development of venous incompetence and varicose veins in adolescents and young adults. Furthermore, it is known to be an a causative factor in the development of unprovoked DVT in younger patients, however data on the risk of development of DVT in MTS patients has to date, been unavailable. The pathogenesis of MTS is largely unknown and whilst the condition is known to be more prevalent in females, familial risk factors are largely unknown. To date, no studies have previously assessed the prevalence of MTS in relatives of those with the condition.

Interventions

OTHERNo Intervention

No Intervention

Sponsors

University Hospital of Limerick
Lead SponsorOTHER

Study design

Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Informed consent, first degree relative with symptomatic May-Thurner syndrome

Exclusion criteria

* Those who not give informed consent to be contacted or to be scanned.

Design outcomes

Primary

MeasureTime frameDescription
Prevalence Assessment1 yearTo assess the prevalence of May-Thurner syndrome amongst 1st-degree relatives of symptomatic individuals referred to the Vascular Department, University Hospital Limerick using duplex ultrasound imaging

Secondary

MeasureTime frameDescription
Venous Competence Assessment1 yearTo assess concomitant venous incompetence of the lower limb

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026